CRL logo

CRL

Charles River Laboratories International Inc.

$163.31
+$0.09(+0.06%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$8.06B
Volume
860.24K
52W Range
$91.86 - $230.02
Target Price
$168.64
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$1.4B$1.7B$1.9B$2.3B$2.6B$2.9B$3.5B$4.0B$4.1B$4.0B
Total Revenue
$1.4B$1.7B$1.3B$1.7B$2.6B$2.9B$3.5B$4.0B$4.1B$4.0B
COST OF GOODS SOLD
Cost of Revenue
$568.2M$757.7M$867.0M$1.2B$1.4B$1.9B$2.2B$2.5B$6.3M$47.0M
GROSS PROFIT
Gross Profit
$531.1M$646.7M$700.9M$840.1M$1.2B$1.1B$1.3B$1.5B$4.1B$4.0B
OPERATING EXPENSES
Operating Expenses
$324.6M$409.2M$412.6M$508.7M$607.2M$640.8M$744.8M$811.7M$885.3M$889.5M
Selling, General & Administrative
$300.4M$367.5M$371.3M$443.9M$517.6M$528.9M$619.9M$665.1M$747.9M$751.0M
Selling & Marketing Expenses
$300.4M$367.5M$371.3M$443.9M------------
General & Administrative Expenses
$-23.4M$-21.8M$-26.3M$-30.4M$517.6M$528.9M$619.9M$665.1M$747.9M$751.0M
Promotion & Advertising
$-1.2M$-1.4M$-1.6M$-1.9M------------
Salaries & Wages
$-40.1M$-43.6M$-44.0M$-47.3M$-9.5M$-8.1M$-10.3M$-11.0M$-10.9M$-10.5M
Depreciation & Amortization
$24.2M$41.7M$41.4M$64.8M$89.5M$111.9M$124.9M$146.6M$137.4M$138.5M
Depreciation & Amortization
$24.2M$41.7M$41.4M$64.8M$89.5M$111.9M$124.9M$146.6M$137.4M$138.5M
Amortization
$24.2M$41.7M$41.4M$64.8M$89.5M$111.9M$124.9M$146.6M$137.4M$138.5M
Other Operating Expenses
$-2.4M$-2.2M$-15.7M$-21.2M$-3.7M$-7.0M$-9.5M$-134.9M$-3.1M$-10.7M
OPERATING INCOME
Operating income
$206.4M$237.4M$288.3M$331.4M$351.2M$432.7M$589.9M$651.0M$617.3M$227.3M
EBITDA
$307.8M$377.3M$457.9M$507.2M$563.1M$768.5M$820.2M$986.1M$3.7B$3.3B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$15.1M$27.7M$29.8M$63.8M$60.9M$86.4M$73.9M$59.3M$1.5M$1.5M
Intinc
$1.0M$1.3M$690.0K$812.0K$1.5M$834.0K$652.0K$780.0K$5.2M$8.6M
Net Non-Operating Interest Income/Expense
$-14.0M$-26.4M$-29.1M$-63.0M$-59.4M$-85.6M$-73.3M$-58.5M$5.2M$8.6M
Gain on Sale of Securities
$3.8M$10.3M$22.9M$15.9M------------
Other Income/Expense
$-3.0M$-11.9M$-37.8M$-13.3M$-12.3M$-100.0M$35.9M$30.5M$-95.5M$16.5M
Other Special Charges
$3.0M$11.9M$37.8M$13.3M$12.3M$100.0M$-35.9M$30.5M$95.5M$-16.5M
SPECIAL ITEMS
Restructring And Mn A Income
$-63.3M$-55.3M$-82.4M$-140.1M$-140.5M$-166.6M$-228.8M$-324.7M$-318.5M$-233.0M
Special Income Charges
$63.3M$57.2M$82.4M$140.1M$140.5M$166.6M$260.7M$327.9M$318.5M$-215.0M
Impairment of Capital Assets
--$-1.9M--------------$215.0M
PRE-TAX INCOME
EBIT
$210.5M$250.6M$326.7M$345.5M$365.0M$533.5M$554.6M$682.3M$3.3B$2.9B
Pre-Tax Income
$195.4M$222.9M$297.0M$281.7M$304.1M$447.1M$480.7M$623.0M$3.3B$2.9B
INCOME TAX
Tax Provision
$43.4M$66.8M$171.4M$54.5M$50.0M$81.8M$81.9M$130.4M$100.9M$67.8M
NET INCOME
Net Income
$152.0M$156.4M$125.6M$228.7M$252.0M$364.3M$391.0M$486.2M$474.6M$22.2M
Net Income (Continuing Operations)
$152.0M$156.4M$125.6M$228.7M$252.0M$364.3M$391.0M$492.6M$3.2B$2.9B
Net Income (Discontinued Operations)
$152.0M$156.4M$125.6M$228.7M$252.0M$364.3M$391.0M$486.2M$474.6M$22.2M
Net Income (Common Stockholders)
$149.3M$154.8M$123.4M$226.4M$252.0M$364.3M$391.0M$486.2M$474.6M$10.3M
Normalized Income
------------------$2.9B
TOTALS
Total Expenses
$892.9M$1.2B$1.3B$1.7B$2.0B$2.2B$2.6B$3.3B$891.6M$936.5M
SHARE & EPS DATA
Average Shares Outstanding
$46.5M$47.0M$47.5M$47.9M$48.7M$49.5M$50.3M$50.8M$51.2M$51.4M
Average Shares Outstanding (Diluted)
$47.6M$48.0M$48.6M$49.0M$49.7M$50.6M$51.4M$51.3M$51.5M$51.6M
Shares Outstanding
$46.7M$47.4M$47.4M$48.2M$49.0M$49.8M$50.5M$51.0M$51.3M$51.1M
Basic EPS
$3.21$3.29$2.6$4.72$5.17$7.35$7.77$9.57$9.27$0.20
Basic EPS (Continuing Operations)
$3.23$3.28$2.6$4.69$5.17$7.35$7.77$9.57$9.27$0.20
Diluted EPS
$3.13$3.23$2.54$4.62$5.07$7.2$7.6$9.48$9.22$0.20
Diluted EPS (Continuing Operations)
$3.15$3.22$2.54$4.59$5.07$7.2$7.6$9.48$9.22$0.20
OTHER METRICS
Accretion On Preferred Stock
--------------$7.5M$-5.7M--
Basic Discontinuous Operations
$-0.02$0.01--$0.03------------
Diluted Discontinuous Operations
$-0.02$0.01--$0.03------------
Earnings from equity interest
$7.3M$7.1M$10.1M$18.2M$-11.4M$-27.6M$-40.2M------
Earnings From Equity Interest Net Of Tax
$7.3M$7.1M$10.1M$18.2M$-11.4M$-27.6M$-40.2M------
Gain On Sale Of Business
--$-788.0K----$20.7M$100.4M$25.0M$123.4M$-961.0K$-659.0K
Gains Loss On Disposal Of Discontinued Operations
$-950.0K$280.0K$-137.0K$1.5M------------
Interest Expense Operating
--------------$-100.8M$-132.1M$-123.5M
Minority Interests
$-1.8M$-1.6M$-2.1M$-2.4M$-2.0M$-1.0M$-7.9M$-6.4M$-5.7M$-3.1M
Net Income Discontinuous Operations
$-950.0K$280.0K$-137.0K$1.5M------------
Other Gand A
$-23.4M$-21.8M$-26.3M$-30.4M$517.6M$528.9M$619.9M$665.1M$747.9M$751.0M
Other Write Off
--$-500.0K------------$3.8M$22.2M
Otherunder Preferred Stock Dividend
--------------$7.5M$-5.7M--
Preferred Stock Dividends
--------------$7.5M$-5.7M--
Rent And Landing Fees
$-23.4M$-21.8M$-26.3M$-30.4M------------
Selling Expense
$300.4M$367.5M$371.3M$443.9M------------
Write Down
------------$-31.9M$-3.2M----
Restruct
$-63.3M$-55.3M$-82.4M$-140.1M$-140.5M$-166.6M$-228.8M$-324.7M$-318.5M$-233.0M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CRL$163.31+0.1%860.24K
3
4
5
6

Get Charles River Laboratories International Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.